Zydus Lifesciences Limited has completed the extinguishment of 87,30,158 (eighty seven lakh thirty thousand one hundred and fifty eight) fully paid-up equity shares with face value of ₹1 each that were bought back through a tender offer process. The shares were repurchased at a price of ₹1,260 per equity share for an aggregate amount not exceeding ₹1,100 crore (₹1100,00,00,000), in compliance with SEBI (Buy-Back of Securities) Regulations, 2018.
The extinguishment was executed on June 18, 2026, as confirmed by National Securities Depository Limited. All 87,30,158 shares were in dematerialized form with zero shares in physical form.
Share Capital Reconciliation
Pre-extinguishment share capital: 100,62,33,990 fully paid-up equity shares of ₹1 each, totaling ₹100,62,33,990
Shares extinguished: 87,30,158 equity shares (all dematerialized)
Post-extinguishment share capital: 99,75,03,832 fully paid-up equity shares of ₹1 each, totaling ₹99,75,03,832
The authorized share capital remains unchanged at 172,50,00,000 equity shares of ₹1 each, totaling ₹172,50,00,000.
Shareholding Pattern Impact
The buyback resulted in the following changes to the shareholding pattern (as of record date May 29, 2026):
Promoter and Promoter Group:
- Pre-buyback: 75,46,25,314 shares (74.99%)
- Post-buyback: 74,82,73,673 shares (75.01%)
Non-Promoter Shareholders:
- Pre-buyback: 25,16,08,676 shares (25.01%)
- Post-buyback: 24,92,30,159 shares (24.99%)
Breakdown of non-promoter categories pre-buyback:
- Foreign Investors: 7,23,96,233 shares (7.19%)
- Financial Institutions/Banks/Mutual Funds/Insurance/Government Companies: 11,14,15,893 shares (11.08%)
- Others (Individuals, Bodies Corporate, Employees, etc.): 6,77,96,550 shares (6.74%)
Documents Submitted
- Annexure A: Pre and post-buyback shareholding pattern
- Annexure B: NSDL confirmation letter dated June 18, 2026
- Annexure C: Certificate of extinguishment dated June 19, 2026
The company has requested the stock exchanges to take this information on record.